Jehmlich K, Sablotni J, Simon B J, Burckhardt G
Max-Planck-Institut für Biophysik, Frankfurt/Main, Federal Republic of Germany.
Kidney Int Suppl. 1991 Jul;33:S64-70.
Brush-border membranes from rat kidney cortex are transiently exposed to cholate to reorient ATP-driven H+ pumps to the outside of the vesicles. The carboxyl group reagent, N,N'-dicyclohexylcarbodiimide (DCCD), inhibits ATP-driven H+ uptake into cholate-pretreated vesicles irreversibly. Complete inhibition requires treatment of vesicles with 0.2 mM DCCD for greater than or equal to 15 min. ATP and ADP do not protect the H+ pump from inactivation suggesting that DCCD modifies pump subunits involved in H+ translocation, but not those related to ATP hydrolysis. With [14C]DCCD a 16 kDa protein is strongly labeled in brush-border and endosomal membranes, but not in basolateral membranes. Molecular mass of this protein and distribution similar to H(+)-ATPases suggest a role as H(+)-conducting subunit of the H+ pumps. The SH-group reagent, N-ethylmaleimide (NEM), also inhibits ATP-driven H+ uptake irreversibly. As opposed to DCCD, ATP and ADP protect the pump from irreversible inhibition indicating that NEM modifies SH-groups in the proximity of ATP hydrolysis sites. Finally, 15 nM of a potent inhibitor of vacuolar ATPases, bafilomycin B1, abolishes ATP-driven H+ uptake. Inactivation by DCCD and NEM, labeling of 16 kDa subunits by [14C]DCCD, and high sensitivity to bafilomycin indicate that the H+ pump (H(+)-ATPase) in rat renal brush-border membranes belongs to the class of vacuolar ATPases. Bafilomycin may prove a valuable tool for specific inhibition of the renal H(+)-ATPase in future studies.
将大鼠肾皮质的刷状缘膜短暂暴露于胆酸盐,以使ATP驱动的H⁺泵重新定向到囊泡外部。羧基试剂N,N'-二环己基碳二亚胺(DCCD)不可逆地抑制ATP驱动的H⁺摄取到经胆酸盐预处理的囊泡中。完全抑制需要用0.2 mM DCCD处理囊泡15分钟或更长时间。ATP和ADP不能保护H⁺泵免于失活,这表明DCCD修饰参与H⁺转运的泵亚基,而不是与ATP水解相关的亚基。用[¹⁴C]DCCD标记时,一种16 kDa的蛋白质在刷状缘膜和内体膜中被强烈标记,但在基底外侧膜中未被标记。该蛋白质的分子量和分布与H⁺-ATP酶相似,表明其作为H⁺泵的H⁺传导亚基发挥作用。巯基试剂N-乙基马来酰亚胺(NEM)也不可逆地抑制ATP驱动的H⁺摄取。与DCCD相反,ATP和ADP保护泵免于不可逆抑制,表明NEM修饰ATP水解位点附近的巯基。最后,15 nM的液泡ATP酶强效抑制剂巴弗洛霉素B1消除了ATP驱动 H⁺摄取。DCCD和NEM导致的失活、[¹⁴C]DCCD对16 kDa亚基的标记以及对巴弗洛霉素的高敏感性表明,大鼠肾刷状缘膜中的H⁺泵(H⁺-ATP酶)属于液泡ATP酶类别。在未来的研究中,巴弗洛霉素可能被证明是特异性抑制肾H⁺-ATP酶的有价值工具。